29 November 2021>: Clinical Research
Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension
Xinhua Zou AB , Miao Xue BCDE , Jiaping Li EFG*DOI: 10.12659/MSM.934436
Med Sci Monit 2021; 27:e934436
Figure 2 (A) The examination of esophageal and gastric varices (white arrow), peritoneal effusion, and hepatocellular carcinoma by computed tomography (CT) in patients. (B) The effective shunt function of the stent through angiography under transjugular intrahepatic portosystemic shunt (TIPS), with implantation of 8×70-mm Viatorr stent. (C) In patients undergoing transarterial chemoembolization (TACE), the staining of hepatocellular carcinoma was obvious and embolization with drug-loaded microspheres was performed. (D) At the 1-month follow-up after TACE, most of the hepatocellular carcinoma was necrotic, the stent was unobstructed, and the peritoneal effusion disappeared.